Chronic kidney disease trials recruiting in Connecticut

All Chronic kidney disease trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · Connecticut: Bloomfield
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Britain
• A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
  NCT06933472 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Connecticut: Orange
• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
  NCT06712654 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Middlebury, Orange
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Hartford, Middlebury, Waterbury
• An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
  NCT05106387 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · Connecticut: New Haven
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Connecticut: West Haven
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Bloomfield, Middlebury
• Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
  NCT03803423 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Ertugliflozin in Chronic Heart Failure
  NCT04438213 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
  NCT05465044 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: West Haven
• Kidney Precision Medicine Project
  NCT04334707 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Study of BHV-1400 in IgA Nephropathy
  NCT07054684 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: Farmington
• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
  NCT07271186 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Connecticut: New Haven
• Transformative Research in Diabetic Nephropathy
  NCT02986984 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Connecticut: New Haven